LATUDA
Total Payments
$23.4M
Transactions
374,144
Doctors
27,475
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2023 | $3,842 | 236 | 188 |
| 2022 | $770,524 | 49,806 | 8,324 |
| 2021 | $1.1M | 63,928 | 10,812 |
| 2020 | $1.7M | 28,137 | 5,729 |
| 2019 | $4.0M | 62,399 | 8,713 |
| 2018 | $7.5M | 77,442 | 9,738 |
| 2017 | $8.3M | 92,196 | 12,082 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $13.6M | 6,460 | 57.9% |
| Food and Beverage | $6.4M | 354,162 | 27.2% |
| Travel and Lodging | $2.0M | 9,185 | 8.7% |
| Unspecified | $935,285 | 1,668 | 4.0% |
| Grant | $304,986 | 4 | 1.3% |
| Consulting Fee | $182,559 | 271 | 0.8% |
| Space rental or facility fees (teaching hospital only) | $13,850 | 11 | 0.1% |
| Education | $11,047 | 2,383 | 0.0% |
Payments by Type
General
$22.5M
372,476 transactions
Research
$935,285
1,668 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| PEDIATRIC OPEN-LABEL EXTENSION STUDY | Sunovion Pharmaceuticals Inc. | $676,841 | 2 |
| LURASIDONE PEDIATRIC BIPOLAR STUDY | Sunovion Pharmaceuticals Inc. | $244,381 | 1 |
| PEDIATRIC SCHIZOPHRENIA EFFICACY AND SAFETY STUDY | Sunovion Pharmaceuticals Inc. | $14,064 | 1 |
Top Doctors Receiving Payments for LATUDA
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Prakash Masand | — | New York, NY | $1.1M | 1,734 |
| , MD | Psychiatry | Bartlett, TN | $316,569 | 402 |
| , M.D | Psychiatry | Albemarle, NC | $309,937 | 444 |
| , M.D | Psychiatry | Newburyport, MA | $306,624 | 678 |
| Vladimir Maletic | — | Greer, SC | $288,568 | 321 |
| , MD | Psychiatry | Stanford, CA | $287,645 | 641 |
| , M.D | Addiction Medicine | Chicago, IL | $257,376 | 348 |
| , MD, MPH | Psychiatry | Pomona, NY | $229,789 | 304 |
| , MD | Psychiatry | Lake Jackson, TX | $221,384 | 312 |
| , M.D., PH.D | Psychiatry | San Rafael, CA | $220,734 | 214 |
| , PHD | Psychiatry | Wichita, KS | $213,720 | 298 |
| , DO | Psychiatry | Brooklyn, NY | $213,427 | 253 |
| , M.D | Psychiatry | Loganville, GA | $212,734 | 381 |
| , MD | Specialist | Carlsbad, CA | $208,810 | 29 |
| , M.D | Psychiatry | Roanoke, VA | $208,166 | 315 |
| , MD | Psychiatry | Gainesville, FL | $206,129 | 430 |
| , MD | Psychiatry | Sioux Falls, SD | $204,064 | 323 |
| , MD | Psychiatry | Orange, CA | $202,546 | 271 |
| , MD | Child & Adolescent Psychiatry | Winona, MN | $202,022 | 359 |
| , M.D | Psychiatry | Oceanside, CA | $201,524 | 240 |
| , MD | Psychiatry | New Canaan, CT | $198,446 | 318 |
| , MD | Psychiatry | Johnston, RI | $192,232 | 206 |
| , M.D | Psychiatry | Saint Louis, MO | $185,528 | 433 |
| , M.D | Psychiatry | San Diego, CA | $182,056 | 226 |
| , M.D | Psychiatry | Chevy Chase, MD | $181,902 | 289 |
Ad
Manufacturing Companies
- Sunovion Pharmaceuticals Inc. $23.4M
- Sumitomo Pharma America, Inc. $3,842
Product Information
- Type Drug
- Total Payments $23.4M
- Total Doctors 27,475
- Transactions 374,144
About LATUDA
LATUDA is a drug associated with $23.4M in payments to 27,475 healthcare providers, recorded across 374,144 transactions in the CMS Open Payments database. The primary manufacturer is Sunovion Pharmaceuticals Inc..
Payment data is available from 2017 to 2023. In 2023, $3,842 was paid across 236 transactions to 188 doctors.
The most common payment nature for LATUDA is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($13.6M, 57.9% of total).
LATUDA is associated with 3 research studies, including "PEDIATRIC OPEN-LABEL EXTENSION STUDY" ($676,841).